Gina Keep
Nurse Practitioner · Massapequa, NYNPI 1275510521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 677 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 677 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- AstraZeneca$2K
- GSK$2K
- Amgen$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$933
- Lilly USA, LLC$846
- plus $6K from 36 others
What the payments were for
- Food & beverage$17,465100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,490 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 113 | $202,440 |
| EliquisApixaban | 81 | $67,138 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 56 | $41,695 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 59 | $38,958 |
| XareltoRivaroxaban | 87 | $38,621 |
| RybelsusSemaglutide | 18 | $31,360 |
| VascepaIcosapent Ethyl | 30 | $28,659 |
| MounjaroTirzepatide | 25 | $25,765 |
| VraylarCariprazine Hcl | 30 | $25,039 |
| JanuviaSitagliptin Phosphate | 28 | $21,253 |
| EntrestoSacubitril/Valsartan | 14 | $13,415 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $12,190 |
| NamzaricMemantine Hcl/Donepezil Hcl | 15 | $9,367 |
| Ursodiol | 16 | $7,452 |
| TradjentaLinagliptin | 26 | $7,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $148 | $233,801131 claims |
| AbbVieVraylar, Namzaric, Linzess, Synthroid | $3,995 | $45,22597 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,428 | $42,56575 claims |
| GSKTrelegy Ellipta | $1,937 | $41,69556 claims |
| Johnson & JohnsonXarelto | $246 | $38,62187 claims |
| MerckJanuvia, Janumet | $157 | $33,44345 claims |
| Lilly USA, LLCMounjaro | $846 | $25,76525 claims |
| NovartisEntresto | $114 | $13,41514 claims |
| Boehringer IngelheimTradjenta | $547 | $7,32826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Massapequa
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.